Martin Burke, DO
Clinical Cardiac Electrophysiology · Chicago, ILNPI 1912917030
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (58.9%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 82.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $54,658 and has fallen 60.1% since, to $21,805 in 2025. Among clinical cardiac electrophysiology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 261 payments — averaging $702.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$152K
- Cvrx, Inc.$21K
- Biosense Webster, Inc.$10K
- Abbott$340
- Medtronic$206
- Novartis$148
- plus $292 from 7 others
Across 63 payments — averaging $1342.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$83K
- Abbott$2K
- Cvrx, Inc.$300
What the payments were for
- Consulting fees$108,05159%
- Speaking & faculty fees$35,75020%
- Travel & lodging$32,15218%
- Food & beverage$7,3564%
- Education$180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 211 | $151,502 |
| Cvrx, Inc. | 19 | $20,569 |
| Biosense Webster, Inc. | 12 | $10,270 |
| Abbott | 4 | $340 |
| Medtronic | 3 | $206 |
| Novartis | 2 | $148 |
| Sanofi-aventis U.S. LLC | 1 | $88 |
| Pfizer | 2 | $73 |
| Johnson & Johnson | 2 | $46 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Kestra Medical Technology Services, Inc. | 1 | $21 |
| Biotronik Inc. | 1 | $18 |
| Elutia, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$52,517
- LUX-Dx Insertable Cardiac Monitor$45,337
- Barostim Neo System$20,356
- CLINICAL TRIAL PRODUCT$11,802
- Carto 3 System$9,664
- Carto Smarttouch$9,664
- CartoSound$9,664
- S-ICD System Magnet$8,262
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$6,940
- Carto CFAE$6,044
- EMBLEM$2,500
- GENERAL PAIN MANAGEMENT$898
- GENERAL VASCULAR ACCESS$385
- Carto 3$365
- GENERAL DBS$338
- Farapulse$150
- AVEIR$130
- WATCHMAN Access System$127
- COSENTYX$125
- Fortify Assura, Ellipse ICD$111
How this compares
$183,326 in reported general payments places this provider in the 90th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
See all clinical cardiac electrophysiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 342 | $391,394 |
| XareltoRivaroxaban | 117 | $145,790 |
| Dofetilide | 354 | $94,423 |
| MultaqDronedarone Hcl | 30 | $41,587 |
| BystolicNebivolol Hcl | 13 | $13,655 |
| Metoprolol Succinate | 408 | $6,588 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 110 | $4,869 |
| SotalolSotalol Hcl | 226 | $3,153 |
| Enoxaparin Sodium | 40 | $1,770 |
| Valsartan | 11 | $1,714 |
| Metoprolol Tartrate | 131 | $1,072 |
| Atorvastatin Calcium | 90 | $939 |
| Losartan Potassium | 95 | $920 |
| Flecainide Acetate | 22 | $900 |
| Lisinopril | 81 | $721 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $73 | $391,394342 claims |
| Johnson & JohnsonXarelto | $46 | $145,790117 claims |
| Sanofi-aventis U.S. LLCMultaq | $88 | $41,58730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
Other clinical cardiac electrophysiology in Chicago
- Roderick TungChicago$795K
- Bradley KnightChicago$661K
- Gaurav UpadhyayChicago$593K
- Hany DemoChicago$297K
- Nishant VermaChicago$232K
- Susan KimChicago$186K
- Arjun MehtaChicago$152K
- Rod PassmanChicago$92K
- Zaid AzizChicago$74K
- Lalit WadhwaniChicago$73K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.